Press Releases

Webcast
SVB Leerink Global Healthcare Conference
Thursday, February 27, 2020 11:00 am EST
Date Title
07/18/17
Summary ToggleT2 Biosystems Receives CE Mark for T2Bacteria™ Panel Enabling Commercialization in Europe Printer Friendly Version New Diagnostic Test Panel Expands Platform Menu Providing Comprehensive T2Sepsis Solution™ for Hospitals LEXINGTON, Mass. , July 18, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health,
06/19/17
Summary ToggleT2 Biosystems Chief Scientific Officer Tom Lowery to Present at BIO 2017 Convention Printer Friendly Version Panel to Discuss Use of Novel Diagnostic Technologies to Improve Patient Care and Aid in Management of Antimicrobials LEXINGTON, Mass. , June 19, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient
06/08/17
Summary ToggleT2 Biosystems to Present at the 2017 Marcum Microcap Conference Printer Friendly Version LEXINGTON, Mass. , June 08, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced that John McDonough , president and chief executive officer, and Darlene Deptula-Hicks , SVP and
06/07/17
Summary ToggleT2 Biosystems Announces New T2Sepsis Solution™ Clinical and Economic Results Presented by Leading Experts at ASM Microbe 2017 Conference Printer Friendly Version Clinical Experts Discuss T2Bacteria TM Early Experience and Potential Emergency Department Applications T2Candida ® Panel Users Present Compelling Rationale for Adoption, Implementation Process, and the Positive Clinical and Economic Results LEXINGTON, Mass.
06/01/17
Summary ToggleStudy Published in the Journal of Clinical Microbiology Highlights Detection of Lyme Disease-Causing Bacteria in Blood Using T2 Biosystems’ T2MR® Technology Printer Friendly Version Data show strong evidence that Lyme disease-causing bacteria exist in blood and that T2MR has superior sensitivity to conventional PCR methods for direct detection in blood. LEXINGTON, Mass. , June 01, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development
05/30/17
Summary ToggleT2 Biosystems to Present at the Jefferies 2017 Global Healthcare Conference Printer Friendly Version LEXINGTON, Mass. , May 30, 2017 (GLOBE NEWSWIRE) --   T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced that John McDonough , president and chief executive officer, and Darlene Deptula-Hicks , SVP
05/24/17
Summary ToggleT2 Biosystems Announces Presentations at ASM Microbe 2017 Conference Printer Friendly Version LEXINGTON, Mass. , May 24, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced two Industry & Science Showcases during the American Society for Microbiology (ASM) Microbe
05/19/17
Summary ToggleHenry Ford Health System to Present Webinar on Positive Clinical Impact of T2 Biosystems’ T2Candida® Panel Printer Friendly Version Webinar to be hosted by Dr. George Alangaden, Senior Staff Physician Director, Henry Ford Hospital LEXINGTON, Mass. , May 19, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. , (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health and deliver a strong economic
05/02/17
Summary ToggleT2 Biosystems Reports First Quarter 2017 Results and Corporate Update Printer Friendly Version LEXINGTON, Mass. , May 02, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc . (NASDAQ:TTOO) today announced operating highlights and financial results for the first quarter ended March 31, 2017 . Recent Operational and First Quarter Performance Highlights: Secured commitments from new hospitals in the
05/01/17
Summary ToggleT2 Biosystems Names Darlene Deptula-Hicks as Chief Financial Officer Printer Friendly Version LEXINGTON, Mass. , May 01, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc . (NASDAQ:TTOO) today announced that Darlene Deptula-Hicks has been named senior vice president and chief financial officer. Ms. Deptula-Hicks is an accomplished financial executive in the life sciences and medical technology